| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/20/2006 | CA2127700C Marek's disease virus recombinant poxvirus vaccine |
| 06/17/2006 | CA2585798A1 Process for the control of production of fine chemicals |
| 06/15/2006 | WO2006063362A1 Fgf18 production in prokaryotic hosts |
| 06/15/2006 | WO2006063242A1 Methods and compositions for induction of tumor regression |
| 06/15/2006 | WO2006063213A2 Serum amyloid a protein in inflammation and obesity |
| 06/15/2006 | WO2006063182A2 Orthopic reconstituted human breast tumor model in mouse |
| 06/15/2006 | WO2006063075A2 Hemipteran octopamine receptor |
| 06/15/2006 | WO2006063065A2 Detection of nucleic acids from multiple types of human papillomaviruses |
| 06/15/2006 | WO2006062543A1 A method of purifying recombinant msp 1-42 derived from plasmodium falciparum |
| 06/15/2006 | WO2006062094A1 Novel cancer antigen peptide and the use thereof |
| 06/15/2006 | WO2006061965A1 Detection/measurement of malaria infection disease utilizing natural immunity by hemozoin induction, screening of preventive or therapeutic medicine for malaria infection disease, and regulation of natural immunity induction |
| 06/15/2006 | WO2006061851A2 Method for production of a therapeutically pure granulocyte macrophage - colony stimulating factor |
| 06/15/2006 | WO2006061650A2 Methods, products and uses involving platelets and/or the vasculature |
| 06/15/2006 | WO2006061628A1 Tgr3-like protein receptor |
| 06/15/2006 | WO2006061406A2 Antimicrobial peptides, polypeptides comprising same, methods for preparing same, genes coding for said peptides, vectors, transformed organisms and compositions containing same |
| 06/15/2006 | WO2006061242A2 Use of pta peptides for stratification of individuals having cancer |
| 06/15/2006 | WO2006061217A2 Saquinavir derivatives useful in immunoassay |
| 06/15/2006 | WO2006060969A1 Peptides which mimic the antigenic regions of the hepatitis a virus |
| 06/15/2006 | WO2006060914A1 Plant proteins having an abscisic acid binding site and methods of use |
| 06/15/2006 | WO2006060903A1 Signal peptides, nucleic acid molecules and methods of treatment |
| 06/15/2006 | WO2006047367A3 Suppression of endogenous immunoglubolin expression in non-human transgenic animals |
| 06/15/2006 | WO2006043972A8 Chimeric protein |
| 06/15/2006 | WO2006040660A3 Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof |
| 06/15/2006 | WO2006027584A3 Vaccines against neisseria |
| 06/15/2006 | WO2006021584A3 Purification of factor xiii polypeptides from biological materials |
| 06/15/2006 | WO2006016172A3 Cell surface glycoprotein |
| 06/15/2006 | WO2006009920A3 Epitope analogs |
| 06/15/2006 | WO2006009862A3 Amebiasis subunit vaccine |
| 06/15/2006 | WO2006008098A3 P1-34 expression units with corynebacterium glutamicum |
| 06/15/2006 | WO2005123923A3 Inducer specific tetracycline repressor proteins and methods of use thereof |
| 06/15/2006 | WO2005123121A3 Use of dna molecule as vaccine adjuvant |
| 06/15/2006 | WO2005118635A3 Anti-cd3 antibodies and methods of use thereof |
| 06/15/2006 | WO2005117993A3 Method of using adenoviral vectors with improved safety and efficacy for the treatment of cancer |
| 06/15/2006 | WO2005116070A3 Reporter system for detecting signal pathway activation in multiple cell types |
| 06/15/2006 | WO2005115448A8 Multi plasmid system for the production of influenza virus |
| 06/15/2006 | WO2005114217A3 Na+ and ci> coupled transport system for endogenous opioid peptides |
| 06/15/2006 | WO2005112621A3 A murine model of hiv-1 infection |
| 06/15/2006 | WO2005100401A3 Monoclonal antibodies with specificity for fetal erythroid cells |
| 06/15/2006 | WO2005089786A3 Y4 selective receptor agonists for therapeutic interventions |
| 06/15/2006 | WO2005073246A3 Method for preparing kl4 lung surfactant |
| 06/15/2006 | WO2005047516A3 Plant transcriptional regulators |
| 06/15/2006 | WO2005016371A8 IMPROVED RECOMBINANT HUMAN INTERFERON-BETA-1b POLYPEPTIDES |
| 06/15/2006 | WO2005007683A8 Antigen epitopes of the regulatory protein of virulence factor in staphylococcus aureus and their mimotopes and use |
| 06/15/2006 | WO2004094596A8 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 06/15/2006 | WO2004091492A3 Computer-based model for identification and characterization of non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
| 06/15/2006 | WO2004090113A3 L53, a lung cancer associated antigen and uses thereof |
| 06/15/2006 | WO2004083390A3 Virulent systemic feline calicivirus |
| 06/15/2006 | WO2004005892A3 Antimicrobial activity of interferon-inducible elr chemokines |
| 06/15/2006 | WO2001038342A3 Novel peptide dimers as agonists of the erythropoietin (epo) receptor, and associated methods of synthesis and use |
| 06/15/2006 | US20060130174 Transposon and transposase genes of rice, transposase, transformant and method of use |
| 06/15/2006 | US20060130173 Genetic modification of plants for enhanced resistance and decreased uptake of heavy metals |
| 06/15/2006 | US20060130170 Avian transgenesis using a chicken ovalbumin gene region |
| 06/15/2006 | US20060130169 Transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem calls. |
| 06/15/2006 | US20060130168 Using transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem cells |
| 06/15/2006 | US20060130167 Transgenic non-human mammals as models for human pathologies of stem cell origin |
| 06/15/2006 | US20060130166 Transgenic non-human mammals as models for human pathologies of stem cell origin |
| 06/15/2006 | US20060130164 Toll/interleukin-1 receptor adapter protein (TIRAP) |
| 06/15/2006 | US20060130160 Full-length human cDNAs encoding potentially secreted proteins |
| 06/15/2006 | US20060130159 Method of purifying recombinant MSP 1-42 derived from Plasmodium falciparum |
| 06/15/2006 | US20060130158 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains |
| 06/15/2006 | US20060128947 Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor |
| 06/15/2006 | US20060128945 Reaction process |
| 06/15/2006 | US20060128944 Molecular linkers suitable for crystallization and structural analysis of molecules of interest, method of using same, and methods of purifying g protein-coupled receptors |
| 06/15/2006 | US20060128942 Method for protein isolation in anoxic conditions |
| 06/15/2006 | US20060128941 Pokeweed antiviral protein polypeptides with antiviral activity |
| 06/15/2006 | US20060128647 Novel oligonucleotides and treating cardiac disorders by using the same |
| 06/15/2006 | US20060128646 Antisense design |
| 06/15/2006 | US20060128645 Inhibition of proliferation and infiltration of brain tumor cells caused by expression of ampa-type glutamate receptor subunit |
| 06/15/2006 | US20060128631 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 06/15/2006 | US20060128629 Angiogenesis inhibitors, antitumor agents |
| 06/15/2006 | US20060128626 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes |
| 06/15/2006 | US20060128623 Treating cutaneous microbial infections such as Propionibacterium acnes by administering a granulysin peptide that is modified to increase hydrophobicity |
| 06/15/2006 | US20060128620 Useful for therapy and prophylaxis of diseases and disorders related to ACTH, ACTH receptors or corticosteroid secretion, such as premature labor and Cushing's Disease |
| 06/15/2006 | US20060128619 Therapeutic use of modulators of notch |
| 06/15/2006 | US20060128618 Peptide binds erythropoietin receptors; for treatment of anemia and stroke |
| 06/15/2006 | US20060128617 Oligoribonucleotide or peptidic nucleic acid inhibiting function of hepatitis c virus |
| 06/15/2006 | US20060128616 Process for the purification of tnf-binding proteins using imac |
| 06/15/2006 | US20060128615 Ghrh analogues |
| 06/15/2006 | US20060128607 Method for inhibiting "melanoma inhibitory activity" mia |
| 06/15/2006 | US20060128606 Fibrils |
| 06/15/2006 | US20060128017 Process for the production of an active molecule vector used to diffuse active substances and vector thus obtained |
| 06/15/2006 | US20060128016 Fibrin-containing composition |
| 06/15/2006 | US20060127989 Antigenic fragment of human T-lymphotropic virus |
| 06/15/2006 | US20060127985 Cytokine designated 4-1BB ligand and human receptor that binds thereto |
| 06/15/2006 | US20060127983 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/15/2006 | US20060127980 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 06/15/2006 | US20060127979 Capable of generating high titer neutralizing antibody responses against at least two HPV types; prophylactic agents; diagnosis |
| 06/15/2006 | US20060127977 Family of mammalian G protein-coupled heteromeric receptors that specifically bind and/or are specifically activated by sweet taste stimuli such as natural and artificial sweeteners and are expressed by recombinant host cells |
| 06/15/2006 | US20060127973 Dna sequences of major secreted proteins from the ciliate tetrahymena and use thereof |
| 06/15/2006 | US20060127963 Microarray-based analysis of rheumatoid arthritis markers |
| 06/15/2006 | US20060127962 Biomarkers for intro-amniotic inflammation |
| 06/15/2006 | US20060127959 Antibodies that bind M. tuberculosis polypeptides |
| 06/15/2006 | US20060127955 Assay for autoantibodies to folate receptors |
| 06/15/2006 | US20060127941 Nuclear matrix protein fluid assay |
| 06/15/2006 | US20060127937 Novel Survivin interacting protein TPR1 |
| 06/15/2006 | US20060127927 Mammalian IAP gene family, primers, probes, and detection methods |
| 06/15/2006 | US20060127923 Internal ribosomal entry site mediated gene expression |
| 06/15/2006 | US20060127921 PECAM-1-related molecules compositions kit of parts and associated methods of use |
| 06/15/2006 | US20060127914 Nicotinic acetylcholine receptor |
| 06/15/2006 | US20060127897 Delete sequence in m, tuberculosis, method for detecting mycobacteria using these sequences and vaccines |